Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Aditxt, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 18 | 25 | +7 |
| Shares | 625.2K | 1.47M | +840.9K (+134.5%) |
| Value | $1.62M | $2.48M | +$857.5K (+53.0%) |
New holders (8)
Institutions that held Aditxt, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVI Holdings, LLC | 588,942 | $995.0K | 0.06% |
| Susquehanna International Group, LLP | 64,444 | $109.0K | 0.00% |
| Virtu Financial LLC | 62,349 | $105.0K | 0.01% |
| Inspire Advisors, LLC | 15,065 | $25.0K | 0.01% |
| Wolverine Trading, LLC | 12,301 | $20.0K | 0.00% |
| Bank of America Corp | 2,947 | $5.00K | 0.00% |
| Morgan Stanley | 1,500 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 459 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Aditxt, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| UBS Group AG | 3,354 | $9.00K |